Administration of Silodosin via Percutaneous Endoscopic Gastrostomy (PEG) Tube
Preparation Requirements
- Pharmacist consultation is recommended before delivering silodosin through a PEG tube to confirm route suitability and verify that no absorption‑site constraints exist. 1
- Liquid formulations are preferred over solid dosage forms for PEG tube administration because they lower the risk of tube occlusion and improve dosing accuracy. 1
- When only capsules are available, open the capsule and dissolve its contents in an appropriate volume of water (typically 15–30 mL) before administration. 1
Administration Technique
- Flush the PEG tube with 30 mL of water before giving silodosin to ensure tube patency. 1
- Administer silodosin separately from other medications, flushing with 30 mL of water between each drug to prevent drug‑drug interactions and precipitation. 1
- Flush the PEG tube with 30 mL of water after silodosin delivery to guarantee complete administration and maintain tube patency. 1
- Use ENFit‑standard syringes and connectors to avoid misconnections. 1
Critical Pitfalls to Avoid
- Do not shake ENFit syringes to remove residue, as this can expose personnel to the medication and alter the delivered dose. 1
- Do not mix silodosin with other medications or enteral formula before administration because of the risk of interactions and precipitation. 1
- Ensure the PEG tube has an adequate lumen size (minimum 15 Charrière) to prevent clogging with medication preparations. 2
Tube Material Considerations
- Polyurethane PEG tubes are preferred over silicone for medication administration due to better patency retention, although certain drugs may bind to polyurethane. 1
Clinical Context
- Silodosin is an α1‑A adrenergic receptor blocker indicated for lower urinary tract symptoms associated with benign prostatic hyperplasia; patients with neurological disorders who require PEG tubes may also benefit from silodosin therapy. 3